Bifurcation FFR - Helpful or Wasteful?

Slides:



Advertisements
Similar presentations
TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
Advertisements

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
BIFURCATION LESIONS Dr. Tahsin.N
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
DEFER STUDY: 5-YEAR FOLLOW-UP A Multicenter Randomized Study
FFR in specific circumstances Zsolt Piróth MD Gottsegen György Hungarian Institute of Cardiology.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
BURZOTTA F. 1, PAN M. 2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÀREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Final 5 year results from the all-comer COMPARE trial: a prospective randomized comparison between Xience-V and Taxus Liberté TCT 2013 San Francisco Pieter.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Simplifying Serial Lesion Assessment
Intravascular ultrasound (IVUS) in percutaneous coronary interventions – summary of key articles While angiography is routinely used for assessment of.
Adel Gamal, MD and Mohamed Saber, Msc
Complex Coronary Cases
My initial ABSORB experience Assoc. Prof. I. Petrov
Disclosure Statement of Financial Interest
Latvian Centre of Cardiology real-life registry
FFR DECISION MAKING DURING DIAGNOSTIC PROCEDURES
Invasive Assessment of Coronary Artery Disease
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
Individualized pain management plan.
IVUS, FFR, OCT- Which Should I Use For PCI?
Physiologic Lesion Assessment: Advantages and Pitfalls
Updates From NOTION: The First All-Comer TAVR Trial
Quantitative Flow Ratio (QFR)
Clinical Usefulness of Post-Stenting FFR
Clinical Presentation
(DES)+BVS +DCB for long diffuse LAD disease
Carotid Artery Stenting Predictors of procedural and clinical success
Strategy planning in coronary bifurcation stenting
Treating CTOs Is there evidence based data?
Solved & Unsolved Issues
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Harmonized Assessment by Randomized Multicenter Study of OrbusNEich’s COMBO StEnt Japan-USA HARMONEE: Primary Report of A Randomized Trial of a Bioabsorbable.
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
The Tryton Bifurcation Trial:
When IVUS? When FFR? Assessing Intermediate Lesions
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Main Arena II, Tuesday, Oct. 31, First Report Investigations 2
FAVOR II Europe-Japan FAVOR II E-J
OCT-Guided PCI What needs to be done to establish criteria?
On behalf of J. Belardi, M. Leon, L. Mauri,
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Fractional Flow Reserve Workshop
3-Year Clinical Outcomes From the RESOLUTE US Study
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Bifurcation Disease: Simulation Training Curriculum
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
FOR DISTRIBUTION BY MEDTRONIC OFFICE OF MEDICAL AFFAIRS ONLY.
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
Presented at TCT 2006.
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Prevalence of women with advanced maternal age by country.
Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma Treatment‐responsive HCC: patient with complete response.
Presentation transcript:

Bifurcation FFR - Helpful or Wasteful? Allen Jeremias, MD, MSc Director, Interventional Cardiology Research Assoc. Director, Cardiac Catheterization St. Francis Hospital, Roslyn, NY Director, Physiology Core Laboratory Cardiovascular Research Foundation, NY, NY

Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company Consulting Fees/Honoraria Astra Zeneca Volcano/Philips Abbott Vascular Medtronic St. Jude Medical

Why “Physiologic Evaluation” in Bifurcation Lesion? Uniqueness of side branch lesions Various size, various amount of supplying myocardium Side branch ostial lesion is unique Underlying plaque  Eccentric plaque Remodeling  Negative remodeling Mechanisms of ostial narrowing after main branch stenting Carina shift, plaque shift, stent struts, thrombus….. Koo and De Bruyne. Eurointervention 2010;6:J94-J98.

Anatomical and Functional Mismatch Diagonal branch: Minimal lumen diameter: 1.7mm Lumen area: 2.7mm2 Vessel area: 5.0mm2 LAD FFR LAD: Minimal lumen diameter: 1.8mm Lumen area: 2.8mm2 Vessel area: 9.0mm2 Diagonal FFR Courtesy Bon-Kwon Koo, MD, PhD 5

Poor Correlation btw Diameter Stenosis and FFR in Jailed Side Branches Fractional Flow Reserve SNUH SB-FFR registry Park SH & Koo BK, J Ger Cardiol 2012 Ahn JM, et al. JACC intv 2012 Fractional Flow Reserve Kumsars I, et al. Eurointervention 2011 Bellenger, et al. Heart 2007

Physiologic Assessment of Jailed Side Branch Lesions 97 lesions in 92 patients All had >50% angio stenosis and TIMI 3 flow after being jailed by stent All > 2mm in diameter FFR successful in all but 3 lesions No TVR (f/u 10 months) for FFR > 0.75 BK Koo, et al. JACC 2005; 46:633

Reason for Mismatch: Carina Shift Carina shift accentuates lumen eccentricity and results in more angiographic diameter loss than lumen area loss Koo BK, et al. Circ Cardiovasc Interv 2010;3:113

Which side branch is clinically important? Focus more on “myocardial mass at risk” than angiographic parameters ~10% How much % of myocardium is at risk? Hachamovitch, Circulation 2003

What is the ischemic burden of the myocardium?

Shiono Y et al., Catheter Cardiovasc Interv 2014;1;84(3):406-13. Impact of myocardial supply area on transstenotic hemodynamics as determined by FFR Representative cases with mismatch between QCA and FFR. A: Intermediate stenosis (percent diameter stenosis = 53%) was seen in a proximal LAD which had a large‐sized diagonal branch. Because the myocardial area supplied by the coronary artery distal to the stenosis was large (modified APPROACH score = 47.75%), the FFR value was below the ischemic threshold (FFR = 0.58). B: Severe stenosis (percent diameter stenosis = 80%) was found in mid RCA with small myocardial supply area (modified APPROACH score = 9.25%). Then, the FFR value was above the ischemic threshold (FFR = 0.91). APPROACH score, Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease score; FFR, fractional flow reserve; LAD, left anterior descending artery; QCA, quantitative coronary angiography; RCA, right coronary artery. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] IF THIS IMAGE HAS BEEN PROVIDED BY OR IS OWNED BY A THIRD PARTY, AS INDICATED IN THE CAPTION LINE, THEN FURTHER PERMISSION MAY BE NEEDED BEFORE ANY FURTHER USE. PLEASE CONTACT WILEY'S PERMISSIONS DEPARTMENT ON PERMISSIONS@WILEY.COM OR USE THE RIGHTSLINK SERVICE BY CLICKING ON THE 'REQUEST PERMISSIONS' LINK ACCOMPANYING THIS ARTICLE. WILEY OR AUTHOR OWNED IMAGES MAY BE USED FOR NON-COMMERCIAL PURPOSES, SUBJECT TO PROPER CITATION OF THE ARTICLE, AUTHOR, AND PUBLISHER. Shiono Y et al., Catheter Cardiovasc Interv 2014;1;84(3):406-13.  

Shiono Y et al., Catheter Cardiovasc Interv 2014;1;84(3):406-13. Impact of Myocardial Supply Area on Transstenotic Hemodyamics as Determined by FFR Percent Diameter Stenosis Myocardial Supply Area Shiono Y et al., Catheter Cardiovasc Interv 2014;1;84(3):406-13.  

Clinical Significance: Main vs. Side Branch - Responses to 1-minute balloon occlusion -   LAD Diagonal P value Chest pain (VAS score) 5 2 <0.0001 ST elevation ≥ 1mm 92.3% 35.4% 0.001 QTc interval, msec 454.0±45.4 440.4±35.7 0.07 QTc dispersion, msec 83.8±39.2 70.7±28.5 Side branches have much less clinical relevance in terms of symptoms, ischemia and arrhythmic potential Koo BK, et al., JACC Cardiovasc Intervent 2012

Collateral Supply Higher in Branch Vessels assessed by coronary wedge pressure (Pw) Diagonal Pw 39mmHg, Pw/Pa 0.36 LAD Pw 23mmHg, Pw/Pa 0.26 Koo BK, et al., JACC Cardiovasc Intervent 2012

Difference in Collateral Recruitability - LAD vs. Diagonals -   LAD Diagonal P value Pre-intervention FFR 0.67±0.10 0.71±0.11 0.02 Pw, mmHg 21.0±6.5 26.7±9.4 <0.0001 Pw/Pa 0.22±0.07 0.27±0.08 0.001 Pw: coronary wedge pressure, Pa: aortic pressure Diagonal branch has higher Pw and Pw/Pa than LAD and may have higher collateral recruitability and more protection from ischemia Koo BK, et al., JACC Cardiovasc Intervent 2012

Collateral Supply Independent Predictor of Mortality 739 pts with chronic stable angina followed over 10 years Coronary pressure derived ‘collateral flow index’ (CFI) determined during a 1-minute coronary balloon occlusion Independent predictors of 10-year mortality: Age Low CFI Smoking Meier P, et al., Circulation 2007

61 year old woman atypical Chest pain, no ischemia testing How would you treat this bifurcation? Zaiee A, et al. AJC, 2004;93:1404-07

61 year old woman atypical Chest pain, no ischemia testing How would you treat this bifurcation? FFR=0.94 Zaiee A, et al. AJC, 2004;93:1404-07

FFR of “jailed” Circumflex Pre Stent Post Stent FU @ 8 mo Nam CW, et al. Korean Circ J 2011;41:304-7.

FFR of “jailed” Circumflex FFR of “jailed” circumflex in 43 patients after LM cross-over PCI During median 12.5 month follow-up only one adverse event (non-cardiac death) in 37 patients with deferred ostial LCx treatment Kang SJ, et al. Catheter Cardiovasc Intervent 2014;83:545-52.

Kumsars, et al. Eurointervention 2012;7:1155-61. Kissing Balloon Inflation for Jailed Side Branches FFR in 75 “Jailed” side branches from Nordic-Baltic Bifurcation III study (42 with final kissing, 32 without) Final Kissing No Immediately Post PCI 8 Month Follow-Up FFR No difference in clinical outcomes Kumsars, et al. Eurointervention 2012;7:1155-61.

Percent Diameter Stenosis vs. Functional Significance Before PCI After MB stenting After kissing balloon

DKCRUSH-VI Randomized Bifurcation Trial • Chinese Multi-Center Study • 320 Patients • SB at least 2.5mm • Medina 1,1,1/0,1,1 • 9% distal LMCA Chen SL, et al, JACC Cardiovasc Interv 2015

One-year clinical outcomes DKCRUSH-VI Study Design One-year clinical outcomes Angio group (n=160) FFR group (n=160) p Cardiac death, n(%) 1 (0.6) 2 (1.3) 0.56 MI, n(%) 22 (13.8) 19 (11.9) 0.74 TLR, n(%) 8 (5.0) 5 (3.1) 0.57 CABG, n(%) ----- TVR, n(%) 11 (6.9) 9 (5.6) 0.82 MACE, n(%) 29 (18.1) 1.00 ST-def/prob, n(%) • Less SB intervention with FFR (56% vs 63%, p=0.07) • Fewer stents with FFR (26% vs 38%, p=0.01) Chen SL, et al, JACC Cardiovasc Interv 2015

Consensus: FFR in Bifurcations Lassen JF, et al. EuroIntervention 2016;12(1):38‐46

Consensus: FFR in Bifurcations Sawaya FJ, et al. JACC Cardiovasc Interv. 2016;9(18):1861‐78